203 related articles for article (PubMed ID: 6240460)
1. Deficiency in C3b receptors on neutrophils of patients with chronic granulomatous disease and hyperimmunoglobulin-E recurrent infection (Job's) syndrome.
Gaither TA; Gallin JI; Iida K; Nussenzweig V; Frank MM
Inflammation; 1984 Dec; 8(4):429-44. PubMed ID: 6240460
[TBL] [Abstract][Full Text] [Related]
2. Studies of phagocytosis in chronic granulomatous disease.
Gaither TA; Medley SR; Gallin JI; Frank MM
Inflammation; 1987 Jun; 11(2):211-27. PubMed ID: 3034783
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
Wilson JG; Ratnoff WD; Schur PH; Fearon DT
Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
[TBL] [Abstract][Full Text] [Related]
4. Modulation of neutrophil expression of C3b receptors (CR1) by soluble monomeric human C3b.
Porteu F; Mir A; Halbwachs-Mecarelli L
Eur J Immunol; 1987 May; 17(5):629-35. PubMed ID: 2953614
[TBL] [Abstract][Full Text] [Related]
5. Mouse monoclonal antibodies to the human C3b receptor.
Cook J; Fischer E; Boucheix C; Mirsrahi M; Jouvin MH; Weiss L; Jack RM; Kazatchkine MD
Mol Immunol; 1985 May; 22(5):531-9. PubMed ID: 3160931
[TBL] [Abstract][Full Text] [Related]
6. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils.
O'Shea JJ; Brown EJ; Seligmann BE; Metcalf JA; Frank MM; Gallin JI
J Immunol; 1985 Apr; 134(4):2580-7. PubMed ID: 3156186
[TBL] [Abstract][Full Text] [Related]
7. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.
Iida K; Mornaghi R; Nussenzweig V
J Exp Med; 1982 May; 155(5):1427-38. PubMed ID: 6978375
[TBL] [Abstract][Full Text] [Related]
8. Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus.
Yoshida K; Yukiyama Y; Miyamoto T
J Rheumatol; 1987 Jun; 14(3):490-6. PubMed ID: 3498035
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
Fischer E; Appay MD; Cook J; Kazatchkine MD
J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
[TBL] [Abstract][Full Text] [Related]
10. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patients with HIV infection.
Jouvin MH; Rozenbaum W; Russo R; Kazatchkine MD
AIDS; 1987 Jul; 1(2):89-94. PubMed ID: 2966632
[TBL] [Abstract][Full Text] [Related]
12. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.
Tausk FA; McCutchan A; Spechko P; Schreiber RD; Gigli I
J Clin Invest; 1986 Oct; 78(4):977-82. PubMed ID: 2944915
[TBL] [Abstract][Full Text] [Related]
13. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus.
Wilson JG; Jack RM; Wong WW; Schur PH; Fearon DT
J Clin Invest; 1985 Jul; 76(1):182-90. PubMed ID: 4019777
[TBL] [Abstract][Full Text] [Related]
15. Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients.
Jepsen HH; Møller Rasmussen J; Teisner B; Schrøder L; Holmskov U; Jarlbaek L; Isager H; Svehag SE
APMIS; 1990 Jul; 98(7):637-44. PubMed ID: 2144431
[TBL] [Abstract][Full Text] [Related]
16. Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1).
Hogg N; Ross GD; Jones DB; Slusarenko M; Walport MJ; Lachmann PJ
Eur J Immunol; 1984 Mar; 14(3):236-43. PubMed ID: 6368248
[TBL] [Abstract][Full Text] [Related]
17. Quantitative measurement of the bactericidal capability of neutrophils from patients and carriers of chronic granulomatous disease.
Repine JE; Clawson CC
J Lab Clin Med; 1977 Sep; 90(3):522-8. PubMed ID: 408453
[TBL] [Abstract][Full Text] [Related]
18. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
Paccaud JP; Carpentier JL; Schifferli JA
Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
[TBL] [Abstract][Full Text] [Related]
19. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
20. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients.
Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L
Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
